[go: up one dir, main page]

AU2002254469A1 - Aptamer-mediated regulation of gene expression - Google Patents

Aptamer-mediated regulation of gene expression

Info

Publication number
AU2002254469A1
AU2002254469A1 AU2002254469A AU2002254469A AU2002254469A1 AU 2002254469 A1 AU2002254469 A1 AU 2002254469A1 AU 2002254469 A AU2002254469 A AU 2002254469A AU 2002254469 A AU2002254469 A AU 2002254469A AU 2002254469 A1 AU2002254469 A1 AU 2002254469A1
Authority
AU
Australia
Prior art keywords
aptamer
gene expression
mediated regulation
mediated
regulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002254469A
Inventor
Murali Ramachandra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Canji Inc
Original Assignee
Canji Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canji Inc filed Critical Canji Inc
Publication of AU2002254469A1 publication Critical patent/AU2002254469A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002254469A 2002-03-19 2002-03-19 Aptamer-mediated regulation of gene expression Abandoned AU2002254469A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2002/009950 WO2004016638A1 (en) 2002-03-19 2002-03-19 Aptamer-mediated regulation of gene expression

Publications (1)

Publication Number Publication Date
AU2002254469A1 true AU2002254469A1 (en) 2004-03-03

Family

ID=31886095

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002254469A Abandoned AU2002254469A1 (en) 2002-03-19 2002-03-19 Aptamer-mediated regulation of gene expression

Country Status (2)

Country Link
AU (1) AU2002254469A1 (en)
WO (1) WO2004016638A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000020040A1 (en) * 1998-10-08 2000-04-13 University Of Massachusetts Controlling gene expression in living cells

Also Published As

Publication number Publication date
WO2004016638A1 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
AU2002253836A1 (en) Aptamer-mediated regulation of gene expression
AU2003265978A1 (en) A method of regulating gene expression
AU2003261405A1 (en) Regulation of transcription elongation factors
AU2003218483A1 (en) Novel expressed genes
AU2003288686A1 (en) Compositions and systems for the regulation of genes
AU2003236991A1 (en) Representations of processes
AU2003225088A1 (en) Regulation of tnf-alpha
AU2003287254A1 (en) Inhibition of gene expression using rna interfering agents
AU2003222197A1 (en) Inhibition of rna function
AU2003230566A1 (en) Therapeutic regulation of deoxyribonuclease-1-like-3 activity
AU2003259185A1 (en) Process for regulating gene expression
AU2003256931A1 (en) USES OF CIRCADIAN GENE mPER2
AU2002219992A1 (en) Targeted regulation of gene expression
AU2003266271A1 (en) Regulation of human esterase
AU2003302825A1 (en) Method of design using genetic programming
AU2003250329A1 (en) Regulation of novel human asparagine-hydroxylases
AU2002254469A1 (en) Aptamer-mediated regulation of gene expression
GB0306148D0 (en) Regulation of gene expression
AU2003294705A1 (en) NtSM GENE
AU2003233720A1 (en) Regulation of gene expression using chromatin remodelling factors
AU2002317373A1 (en) Control of gene expression
AU2002306951A1 (en) Gene regulation ii
AU2003267384A1 (en) Bhyd gene
AU2003240688A1 (en) Regulation of human kinase
GB0217183D0 (en) Regulation of gene expression

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase